EHC - Encompass Health Corporation
NYSE
->
Healthcare
->
Medical Care Facilities
Birmingham,
United States
Type: Equity
EHC price evolution
EHC
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $182.1 | $172.7 | $104.2 | |
| Short term investments | ||||
| Net receivables | $576.4 | $589.7 | $619.3 | $611.6 |
| Inventory | ||||
| Total current assets | $933.9 | $938.1 | $929.8 | $841.8 |
| Long term investments | ||||
| Property, plant & equipment | $3733.4 | $3655.2 | $3569.4 | $3509.5 |
| Goodwill & intangible assets | $1587 | $1553.5 | $1559.5 | |
| Total noncurrent assets | $5450.6 | $5301.6 | $5260.6 | |
| Total investments | ||||
| Total assets | $6458.4 | $6388.7 | $6231.4 | $6102.4 |
| Current liabilities | ||||
| Accounts payable | $170.3 | $164.2 | $166.1 | $170 |
| Deferred revenue | ||||
| Short long term debt | $59.1 | $51 | $48.9 | |
| Total current liabilities | $897.4 | $694.5 | $680.3 | $656.4 |
| Long term debt | $2344.5 | $2886.1 | $2868.4 | $2883.9 |
| Total noncurrent liabilities | $3164.2 | $3147.7 | $3148.8 | |
| Total debt | $2945.2 | $2919.4 | $2932.8 | |
| Total liabilities | $4498.6 | $3858.7 | $3828 | $3805.2 |
| Shareholders' equity | ||||
| Retained earnings | $693.2 | $602.3 | $503.7 | $406.5 |
| Other shareholder equity | ||||
| Total shareholder equity | $1839.4 | $1741.9 | $1647.5 | |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $104.2 | $53.4 | $119.9 | $289.4 |
| Short term investments | ||||
| Net receivables | $611.6 | $536.8 | $680.3 | $572.8 |
| Inventory | ||||
| Total current assets | $841.8 | $717.2 | $921.4 | $948.6 |
| Long term investments | ||||
| Property, plant & equipment | $3509.5 | $3151.7 | $2843.6 | $2452.3 |
| Goodwill & intangible assets | $1559.5 | $1545.5 | $2845.4 | $2750 |
| Total noncurrent assets | $5260.6 | $4919.3 | $5943.5 | $5497.3 |
| Total investments | ||||
| Total assets | $6102.4 | $5636.5 | $6864.9 | $6445.9 |
| Current liabilities | ||||
| Accounts payable | $170 | $132.9 | $137.6 | $115 |
| Deferred revenue | ||||
| Short long term debt | $48.9 | $50.8 | $81.2 | $83.1 |
| Total current liabilities | $656.4 | $575.9 | $748.8 | $717.3 |
| Long term debt | $2883.9 | $2741.8 | $3457 | $3460.2 |
| Total noncurrent liabilities | $3148.8 | $3234.3 | $3759.1 | $3758.6 |
| Total debt | $2932.8 | $2992.3 | $3538.2 | $3543.3 |
| Total liabilities | $3805.2 | $4326.2 | $4507.9 | $4475.9 |
| Shareholders' equity | ||||
| Retained earnings | $406.5 | $115.7 | $141.8 | -$242.3 |
| Other shareholder equity | $487.9 | $381.6 | ||
| Total shareholder equity | $1647.5 | $1310.3 | $1911.3 | $1588 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1301.2 | $1316 | ||
| Cost of revenue | $962.2 | $988 | ||
| Gross Profit | $339 | $328 | ||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $50.5 | $50.2 | ||
| Total operating expenses | $123.4 | $120.5 | ||
| Operating income | $215.6 | $207.5 | ||
| Income from continuing operations | ||||
| EBIT | $219.1 | $212.3 | ||
| Income tax expense | $38.3 | $38.3 | ||
| Interest expense | $34.3 | $35.2 | ||
| Net income | ||||
| Net income | $146.5 | $138.8 | ||
| Income (for common shares) | $146.5 | $138.8 | ||
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Jan 2022 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $4801.2 | $4348.6 | $4644.4 | |
| Cost of revenue | $3593.8 | $3320.5 | ||
| Gross Profit | $1207.4 | $1028.1 | $4644.4 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $201.7 | $154.3 | $2837.5 | |
| Total operating expenses | $475.6 | $397.9 | $3999.4 | |
| Operating income | $731.8 | $630.2 | $645 | |
| Income from continuing operations | ||||
| EBIT | $738.7 | $641.7 | $656.8 | |
| Income tax expense | $132.2 | $100.1 | $103.8 | |
| Interest expense | $143.5 | $175.7 | $184.2 | |
| Net income | ||||
| Net income | $463 | $365.9 | $368.8 | |
| Income (for common shares) | $463 | $365.9 | $368.8 | |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $146.5 | $138.8 | $119.1 | |
| Operating activities | ||||
| Depreciation | $72.9 | $70.3 | $70.1 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $13.6 | $9.3 | $13.4 | |
| Total cash flows from operations | $217.4 | $238.8 | $201 | |
| Investing activities | ||||
| Capital expenditures | -$156.9 | -$139.4 | -$222.6 | |
| Investments | $1 | $16 | -$1.9 | |
| Total cash flows from investing | -$449.6 | -$158.4 | -$129.7 | -$208.1 |
| Financing activities | ||||
| Dividends paid | -$45.8 | -$14.9 | -$15.9 | -$14.9 |
| Sale and purchase of stock | -$16.8 | |||
| Net borrowings | -$12.1 | -$1 | -$6.1 | |
| Total cash flows from financing | -$179.7 | -$49.6 | -$40.6 | -$29.9 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $94.7 | $9.4 | $68.5 | -$37 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $463 | $365.9 | $517.2 | $368.8 |
| Operating activities | ||||
| Depreciation | $273.9 | $243.6 | $256.6 | $243 |
| Business acquisitions & disposals | -$118.6 | -$1.1 | ||
| Stock-based compensation | $50.6 | $29.2 | $32.8 | $29.5 |
| Total cash flows from operations | $850.8 | $705.8 | $715.8 | $704.7 |
| Investing activities | ||||
| Capital expenditures | -$583.1 | -$574 | -$544.7 | -$404.7 |
| Investments | -$23 | -$35.2 | -$9 | $3.9 |
| Total cash flows from investing | -$602.8 | -$627 | -$666.3 | -$407.5 |
| Financing activities | ||||
| Dividends paid | -$60.4 | -$99 | -$112.4 | -$111.9 |
| Sale and purchase of stock | -$6.1 | |||
| Net borrowings | -$83.3 | -$498.2 | -$66.3 | $206.7 |
| Total cash flows from financing | -$197.2 | -$145.7 | -$240.1 | -$145.9 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $50.8 | -$66.9 | -$190.6 | $151.3 |
News
Fundamentals
| Market cap | $10.28B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 100.75M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 2.31 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.04 |
| Quick ratio | N/A |